How many studies have been conducted on Meloxicam?

BiohacksAI has indexed 299 PubMed studies on Meloxicam, including 57 randomized controlled trials (RCTs). 37% of studies involve human subjects.

What are the main research areas for Meloxicam?

The primary research domains for Meloxicam are 🔬 Inflammation, 💊 Pain, 🦴 Bone & Joint. This is based on analysis of 299 PubMed studies using the BiohacksAI evidence platform.

Meloxicam

A benzothiazine and thiazole derivative that acts as a NSAID and cyclooxygenase-2 (COX-2) inhibitor. It is used in the treatment of RHEUMATOID ARTHRITIS; OSTEOARTHRITIS; and ANKYLOSING SPONDYLITIS.

299+ PubMed studies analyzed · 57 RCTs · Evidence Score: 48

Research Domains

Meloxicam has been studied across 18 research domains including 🔬 Inflammation, 💊 Pain, 🦴 Bone & Joint, 🫁 Liver & Detox, 😴 Sleep. The primary research focus is 🔬 Inflammation with 61% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Meloxicam, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Loading evidence profile...

This evidence profile for Meloxicam is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.